Skip to main content
Top
Published in: Metabolic Brain Disease 4/2016

01-08-2016 | Short Communication

Chronic methamphetamine exposure prior to middle cerebral artery occlusion increases infarct volume and worsens cognitive injury in Male mice

Authors: Damian G. Zuloaga, Jianming Wang, Sydney Weber, Gregory P. Mark, Stephanie J. Murphy, Jacob Raber

Published in: Metabolic Brain Disease | Issue 4/2016

Login to get access

Abstract

Emerging evidence indicates that methamphetamine (MA) abuse can impact cardiovascular disease. In humans, MA abuse is associated with an increased risk of stroke as well as an earlier age at which the stroke occurs. However, little is known about how chronic daily MA exposure can impact ischemic outcome in either humans or animal models. In the present study, mice were injected with MA (10 mg/kg, i.p.) or saline once daily for 10 consecutive days. Twenty-four hours after the final injection, mice were subjected to transient middle cerebral artery occlusion (tMCAO) for one hour followed by reperfusion. Mice were tested for novel object memory at 96 h post-reperfusion, just prior to removal of brains for quantification of infarct volume using 2,3,5-Triphenyltetrazolium Chloride (TTC) staining. Mice treated with MA prior to tMCAO showed decreased object memory recognition and increased infarct volume compared to saline-treated mice. These findings indicate that chronic MA exposure can worsen both cognitive and morphological outcomes following cerebral ischemia.
Literature
go back to reference Anderson CA, Sung GY (2003) Central retinal artery occlusion associated with intranasal methamphetamine use. J Stroke Cerebrovasc Dis 12:207–208CrossRefPubMed Anderson CA, Sung GY (2003) Central retinal artery occlusion associated with intranasal methamphetamine use. J Stroke Cerebrovasc Dis 12:207–208CrossRefPubMed
go back to reference Balkaya M, Kröber J, Gertz K, Peruzzaro S, Endres M (2013) Characterization of long-term functional outcome in a murine model of mild brain ischemia. J Neurosci Methods 213(2):179–187CrossRefPubMed Balkaya M, Kröber J, Gertz K, Peruzzaro S, Endres M (2013) Characterization of long-term functional outcome in a murine model of mild brain ischemia. J Neurosci Methods 213(2):179–187CrossRefPubMed
go back to reference Banerjee A, Wang J, Bodhankar S, Vandenbark AA, Murphy SJ, Offner H (2013) Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice. Transl Stroke Res 4:554–563CrossRefPubMed Banerjee A, Wang J, Bodhankar S, Vandenbark AA, Murphy SJ, Offner H (2013) Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice. Transl Stroke Res 4:554–563CrossRefPubMed
go back to reference Baxter MG (2010) “I’ve seen it all before”: explaining age-related impairments in object recognition. theoretical comment on burke et al. (2010). Behav Neurosci 124:706–709CrossRefPubMed Baxter MG (2010) “I’ve seen it all before”: explaining age-related impairments in object recognition. theoretical comment on burke et al. (2010). Behav Neurosci 124:706–709CrossRefPubMed
go back to reference Bennett BA, Hollingsworth CK, Martin RS, Harp JJ (1998) Methamphetamine-induced alterations in dopamine transporter function. Brain Res 782:219–227CrossRefPubMed Bennett BA, Hollingsworth CK, Martin RS, Harp JJ (1998) Methamphetamine-induced alterations in dopamine transporter function. Brain Res 782:219–227CrossRefPubMed
go back to reference Bowyer JF, Thomas MT, Schmued LC, Ali SF (2008) Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures and the blood-brain barrier. Ann N Y Acad Sci 1139:127–139CrossRefPubMed Bowyer JF, Thomas MT, Schmued LC, Ali SF (2008) Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures and the blood-brain barrier. Ann N Y Acad Sci 1139:127–139CrossRefPubMed
go back to reference Broadbent NJ, Gaskin S, Squire LR, Clark RE (2009) Object recognition memory and the rodent hippocampus. Learn Mem 17:5–11CrossRefPubMed Broadbent NJ, Gaskin S, Squire LR, Clark RE (2009) Object recognition memory and the rodent hippocampus. Learn Mem 17:5–11CrossRefPubMed
go back to reference DeVries AC, Joh HD, Bernard O, Hattori K, Hurn PD, Traystman RJ, Alkayed NJ (2001) Social stress exacerbates stroke outcome by suppressing bcl-2 expression. Proc Natl Acad Sci U S A 98:11824–11828CrossRefPubMedPubMedCentral DeVries AC, Joh HD, Bernard O, Hattori K, Hurn PD, Traystman RJ, Alkayed NJ (2001) Social stress exacerbates stroke outcome by suppressing bcl-2 expression. Proc Natl Acad Sci U S A 98:11824–11828CrossRefPubMedPubMedCentral
go back to reference Dirnagl U (2006) Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab 26:1465–1478CrossRefPubMed Dirnagl U (2006) Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab 26:1465–1478CrossRefPubMed
go back to reference Haley GE, Yeiser L, Olsen RH, Davis MJ, Johnson LA, Raber J (2013) Early effects of whole-body (56)Fe irradiation on hippocampal function in C57BL/6 J mice. Radiat Res 179:590–596CrossRefPubMedPubMedCentral Haley GE, Yeiser L, Olsen RH, Davis MJ, Johnson LA, Raber J (2013) Early effects of whole-body (56)Fe irradiation on hippocampal function in C57BL/6 J mice. Radiat Res 179:590–596CrossRefPubMedPubMedCentral
go back to reference Ho EL, Josephson SA, Lee HS, Smith WS (2009) Cerebrovascular complications of methamphetamine abuse. Neurocrit Care 10:295–305CrossRefPubMed Ho EL, Josephson SA, Lee HS, Smith WS (2009) Cerebrovascular complications of methamphetamine abuse. Neurocrit Care 10:295–305CrossRefPubMed
go back to reference Ohta K, Mori M, Yoritaka A, Okamoto K, Kishida S (2005) Delayed ischemic stroke associated with methamphetamine use. J Emerg Med 28:165–167CrossRefPubMed Ohta K, Mori M, Yoritaka A, Okamoto K, Kishida S (2005) Delayed ischemic stroke associated with methamphetamine use. J Emerg Med 28:165–167CrossRefPubMed
go back to reference Polesskaya O, Silva J, Sanfilippo C, Desrosiers T, Sun A, Shen J, Feng C, Polesskiy A, Deane R, Zlokovic B, Kasischke K, Dewhurst S (2011) Methamphetamine causes sustained depression in cerebral blood flow. Brain Res 1373:91–100CrossRefPubMed Polesskaya O, Silva J, Sanfilippo C, Desrosiers T, Sun A, Shen J, Feng C, Polesskiy A, Deane R, Zlokovic B, Kasischke K, Dewhurst S (2011) Methamphetamine causes sustained depression in cerebral blood flow. Brain Res 1373:91–100CrossRefPubMed
go back to reference Rau T, Ziemniak J, Poulsen D (2016) The neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury. Prog Neuropsychopharmacol Biol Psychiatry 64:231–236 Rau T, Ziemniak J, Poulsen D (2016) The neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury. Prog Neuropsychopharmacol Biol Psychiatry 64:231–236
go back to reference Sharma HS, Ali SF (2006) Alterations in blood-brain barrier function by morphine and methamphetamine. Ann N Y Acad Sci 1074:198–224CrossRefPubMed Sharma HS, Ali SF (2006) Alterations in blood-brain barrier function by morphine and methamphetamine. Ann N Y Acad Sci 1074:198–224CrossRefPubMed
go back to reference Shishido T, Watanabe Y, Suzuki H, Kato K, Niwa S, Hanoune J, Matsuoka I (1997) Effects of repeated methamphetamine administration on dopamine D1 receptor, D2 receptor and adenylate cyclase type V mRNA levels in the rat striatum. Neurosci Lett 222:175–178CrossRefPubMed Shishido T, Watanabe Y, Suzuki H, Kato K, Niwa S, Hanoune J, Matsuoka I (1997) Effects of repeated methamphetamine administration on dopamine D1 receptor, D2 receptor and adenylate cyclase type V mRNA levels in the rat striatum. Neurosci Lett 222:175–178CrossRefPubMed
go back to reference Substance Abuse and Mental Health Services Administration (SAMHSA)(2010) Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Rockville, MD: Office of Applied Studies, SAMHSA. Substance Abuse and Mental Health Services Administration (SAMHSA)(2010) Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Rockville, MD: Office of Applied Studies, SAMHSA.
go back to reference Thiriet N, Deng X, Solinas M, Ladenheim B, Curtis W, Goldberg SR, Palmiter RD, Cadet JL (2005) Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J Neurosci 25:5273–5279CrossRefPubMed Thiriet N, Deng X, Solinas M, Ladenheim B, Curtis W, Goldberg SR, Palmiter RD, Cadet JL (2005) Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J Neurosci 25:5273–5279CrossRefPubMed
go back to reference Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181:151–160CrossRefPubMed Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181:151–160CrossRefPubMed
go back to reference Wang Y, Hayashi T, Chang CF, Chiang YH, Tsao LI, Su TP, Borlongan C, Lin SZ (2001) Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation. Stroke 32:775–782CrossRefPubMed Wang Y, Hayashi T, Chang CF, Chiang YH, Tsao LI, Su TP, Borlongan C, Lin SZ (2001) Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation. Stroke 32:775–782CrossRefPubMed
go back to reference Yamanaka Y, Yamamoto T, Egashira T (1983) Methamphetamine-induced behavioral effects and releases of brain catecholamines and brain concentrations of methamphetamine in mice. Jpn J Pharmacol 33:33–40CrossRefPubMed Yamanaka Y, Yamamoto T, Egashira T (1983) Methamphetamine-induced behavioral effects and releases of brain catecholamines and brain concentrations of methamphetamine in mice. Jpn J Pharmacol 33:33–40CrossRefPubMed
go back to reference Zhu W, Casper A, Libal NL, Murphy SJ, Bodhankar S, Offner H, Alkayed NJ (2015) Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke. Transl Stroke Res 6:60–68CrossRefPubMed Zhu W, Casper A, Libal NL, Murphy SJ, Bodhankar S, Offner H, Alkayed NJ (2015) Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke. Transl Stroke Res 6:60–68CrossRefPubMed
go back to reference Zuloaga KL, Krasnow SM, Zhu X, Zhang W, Jouihan SA, Shangraw RE, Alkayed NJ, Marks DL (2014) Mechanism of protection by soluble epoxide hydrolase inhibition in type 2 diabetic stroke. PLoS ONE 9:e97529CrossRefPubMedPubMedCentral Zuloaga KL, Krasnow SM, Zhu X, Zhang W, Jouihan SA, Shangraw RE, Alkayed NJ, Marks DL (2014) Mechanism of protection by soluble epoxide hydrolase inhibition in type 2 diabetic stroke. PLoS ONE 9:e97529CrossRefPubMedPubMedCentral
go back to reference Zuloaga DG, Johnson LA, Weber S, Raber J (2016) Immediate and lasting effects of chronic daily methamphetamine exposure on activation of cells in hypothalamic-pituitary-adrenal axis-associated brain regions. Psychopharmacology 233(3):381–392CrossRefPubMed Zuloaga DG, Johnson LA, Weber S, Raber J (2016) Immediate and lasting effects of chronic daily methamphetamine exposure on activation of cells in hypothalamic-pituitary-adrenal axis-associated brain regions. Psychopharmacology 233(3):381–392CrossRefPubMed
Metadata
Title
Chronic methamphetamine exposure prior to middle cerebral artery occlusion increases infarct volume and worsens cognitive injury in Male mice
Authors
Damian G. Zuloaga
Jianming Wang
Sydney Weber
Gregory P. Mark
Stephanie J. Murphy
Jacob Raber
Publication date
01-08-2016
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 4/2016
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-016-9808-z

Other articles of this Issue 4/2016

Metabolic Brain Disease 4/2016 Go to the issue